INTRODUCTION
It is estimated that 50-70% of human conceptions fail, making pregnancy loss the commonest complication of pregnancy. 1 Recurrent pregnancy loss, which can be defined as two or more consecutive pregnancy losses, is a devastating reproductive problem affecting B5% of couples attempting to conceive. 2 Pregnancy loss has multiple etiologies. Besides chromosomal, anatomic, and endocrine factors, immunologic etiologies have long been proposed to be associated with this disease. 3 A large body of evidence indicates that infections are associated with pregnancy loss. 4 About 15% of early miscarriages and 66% of late miscarriages have been attributed to infections. 5, 6 Natural killer T (NKT) cells are a distinct T-cell subset that is present in human and mouse decidua. 7, 8 In contrast to conventional T (Tcon) cells that recognize peptide antigens, NKT cells respond to lipid in the context of the atypical major histocompatibility complex class I molecule CD1d. 9 The bestcharacterized NKT cells are invariant NKT (iNKT) cells or type I NKT cells. iNKT cells express a semi-invariant T-cell receptor (TCR) composed of an invariant TCR a chain (Va14-Ja18 in mice and Va24-Ja18 in humans) that pairs with a limited selection of TCR b chains. 10 An important feature of iNKT cells is their ability to promptly produce a large number of cytokines, including interferon (IFN)-g and interleukin (IL)-4, in response to TCR engagement. 11 This rapid induction of cytokine production contributes to the recruitment and activation of other immune cells, including Tcon cells, B cells, natural killer (NK) cells, dendritic cells, macrophages, neutrophils, and regulatory T (Treg) cells, thereby influencing a wide range of immunological responses. 11 Treg cells are a special group of CD4 þ T cells that express the transcription factor forkhead box p3 (Foxp3) and suppress the activation, proliferation, and effector function of a variety of immune cells, including CD4 þ and CD8 þ T cells, B cells, NK cells, and antigen-presenting cells in vivo and in vitro. 12 There are two main subsets of Treg cells. One is naturally occurring Treg cells that develop in the thymus; the other is induced Treg cells that are thought to arise in the periphery from naive CD4 acute and chronic infections, metabolic inflammation, tissue injury, and tumor immunity.
14 Foxp3 is not only the marker of Treg cells but also critical for the differentiation and function of Treg cells. 15 Dysfunction of Foxp3 results in congenital Treg cell deficiency and severe systemic immunopathology in both mice and humans, 16, 17 indicating that Treg cells are indispensable for immune homeostasis. In addition, Treg cells have been suggested to have an important role in maternal-fetal immune tolerance. 13 Depletion of Treg cells before pairing results in infiltration of activated T effector cells, uterine inflammation and fibrosis, and impaired implantation in both allogeneic and syngeneic mating combinations, suggesting that Treg cells are necessary for successful implantation. 18 Shima et al. 19 have also reported that Treg cell depletion using an anti-CD25 antibody (Ab) in allogeneic and syngeneic pregnant mice induces implantation failure.
iNKT cells become activated in response to microbial lipid antigens, such as those derived from Plasmodium 20 and Leishmania. 21 Both pathogens are known to induce abortion at high frequency. In addition, iNKT cells are able to recognize exogenous lipid antigens, such as a-galactosylceramide (aGC). Upon recognizing the prototypical lipid aGC, iNKT cells are able to rapidly produce both T helper type 1 (Th1) and T helper type 2 (Th2) cytokines. 22 As a strong agonist for iNKT cells, aGC has been extensively used as a model antigen for iNKT cell studies, 22 although several of its analogs have been synthesized to specifically induce either Th1 or Th2 responses. 23, 24 Activation of iNKT cells through intraperitoneal (IP) injection of aGC induces rapid pregnancy loss in mice and has been proposed as a model of infection-mediated pregnancy loss. 8 However, the mechanisms underlying iNKT cell-mediated pregnancy loss are poorly defined. In this article, we investigated these mechanisms. We demonstrate that activation of iNKT cells through IP injection of aGC rapidly induces pregnancy loss in mice in an IFN-g-dependent manner. In addition, inhibition of the function of decidual Treg cells has an important role in iNKT cell-mediated pregnancy loss.
RESULTS

IP injection of aGC rapidly activates decidual iNKT cells
We first investigated whether IP injection of aGC on day 9.5 of gestation could activate decidual iNKT cells as assessed by the percentage of iNKT cells in the decidua and the production of intracellular IFN-g and IL-4 by decidual iNKT cells. IP injection of aGC significantly increased the percentage of decidual iNKT cells 12 h after aGC treatment (Po0.01; Figure 1a ). Exposure to aGC markedly upregulated the intracellular production of IFN-g (Po0.01; Figure 1b ) and IL-4 (Po0.01; Figure 1c ) by decidual iNKT cells. These findings suggest that IP injection of aGC rapidly activates decidual iNKT cells.
Induction of pregnancy loss by aGC requires iNKT cells
To investigate the role of Va14 NKT cells in pregnancy loss, aGC was injected IP into pregnant mice on day 9.5 of gestation. Seventy-two hours later, the number of total fetuses, viable fetuses, and embryo resorption rates (ERRs) were evaluated.
Conventional T cells do not express the invariant Va14-Ja18 antigen receptor, 25 indicating their selective usage in Va14 NKT cells. Thus, disruption of the invariant Va14-Ja18 receptor results in the selective loss of iNKT cells, leaving other types of lymphocytes intact. 8 In our study, the number of total fetuses, viable fetuses, ERR, and the appearance of the fetuses in vehicle-treated Ja18 À / À mice did not differ from vehicle-treated wild-type (WT) C57BL/6 mice (Figure 2a,b) . Our data confirm that iNKT cell-deficient Ja18 À / À mice that lack invariant Va14-Ja18 TCR expression are fertile despite a loss of Va14 NKT cells. 26 Treatment with aGC markedly decreased the number of viable fetuses and increased the ERR in WT mice (Po0.01 for both comparisons) (Figure 2a) , suggesting an important involvement of iNKT cells in aGC-induced miscarriage. Administration of aGC to pregnant C57BL/6 mice on day 9.5 of gestation rapidly induced pregnancy loss characterized by very small fetal size and hemorrhage by 72 h after aGC injection (Figure 2b) .
The number of total fetuses, viable fetuses, and the ERR in aGC-treated Ja18 À / À mice was not different from vehicletreated WT or Ja18 À / À mice ( Figure 2a) . Furthermore, the fetal appearance in aGC-injected Ja18 À / À mice did not differ from vehicle-treated WT or Ja18 À / À mice ( Figure 2b ). These results indicate that a deficiency in iNKT cells fails to induce pregnancy loss induced by aGC.
Administration of aGC upregulates serum cytokines in WT mice, but not in Ja18
As the administration of aGC promoted the secretion of cytokines at the maternal-fetal interface, we wondered whether treatment with aGC could affect systemic cytokine production. As shown in Figure 2c , stimulation with aGC notably increased not only the levels of the Th1 cytokines IFN-g and tumor necrosis factor (TNF)-a but also the production of the Th2 cytokines IL-4 and IL-10 in the serum from WT mice (Po0.01, respectively). However, administration of aGC had no effect on the production of those cytokines in the serum from Ja18
mice. In addition, the production of those cytokines in the serum from vehicle-treated Ja18 À / À mice did not differ from vehicle-treated WT mice. Our data demonstrate that deficiency of iNKT cells decreases aGC-mediated upregulation of serum cytokine production. iNKT cells notably increased the ERR in aGC-stimulated Ja18 À / À mice (Po0.01 for both comparisons; Figure 3a ). These findings further confirm a role for iNKT cells in aGCinduced pregnancy loss and this effect is IFN-g-dependent, but not IL-4-dependent. As IFN-g signaling appeared to be essential in iNKT cell-induced pregnancy loss using a knockout model, we further investigated the role of IFN-g in fetal loss by using IP injection of recombinant mouse IFN-g into pregnant WT mice. As shown in Figure 3b , administration of IFN-g significantly increased the ERR in WT mice (Po0.01).
We also investigated the effects of adoptive transfer of iNKT cells on the levels of serum cytokines. Adoptive transfer of iNKT cells from WT and IL-4 À / À mice into aGC-exposed Ja18 À / À mice significantly upregulated the production of the serum cytokines IFN-g, TNF-a, IL-4, and IL-10 (Po0.01, respectively; Figure 3c ). However, adoptive transfer of iNKT cells from IFN-g À / À mice into aGC-exposed Ja18 À / À mice did not affect the production of serum cytokines (Figure 3c ). These findings show that iNKT cells can promote systemic cytokine production and this effect requires IFN-g but not IL-4. 
Adoptive transfer of Treg cells inhibits aGC-induced pregnancy loss
As Treg cells are crucial in maintaining maternal-fetal immune tolerance, we wondered whether Treg cells have a role in iNKT cell-mediated pregnancy loss as well. As shown in Figure 5 , the number of total fetuses did not differ among vehicle-treated WT mice and aGC-treated WT mice with or without adoptive transfer of Treg cells. Nevertheless, the number of viable fetuses in aGC-treated WT mice with Treg cell adoptive transfer was markedly higher than aGC-treated WT mice without adoptive transfer of Treg cells (Po0.01), but was still lower than vehicletreated control mice (Po0.01). In addition, the ERR of aGCtreated WT mice with adoptive transfer of Treg cells was strikingly lower than that of aGC-treated WT mice without adoptive transfer of Treg cells (Po0.01), but was still higher than vehicle-treated control mice (Po0.01). Our data suggest that iNKT cell-mediated pregnancy loss occurs at least partly through suppression of Treg cells. 
DISCUSSION
The production of both Th1 (IFN-g) and Th2 (IL-4) cytokines is a hallmark of iNKT cell activation. 11 In the present study, we showed that IP injection of aGC into C57BL/6 mice promptly activated decidual iNKT cells as assessed by the elevated frequency of decidual iNKT cells and their intracellular production of IFN-g and IL-4. In addition, IP injection of aGC not only increased IFN-g and IL-4 at the maternal-fetal interface but also upregulated Th1 cytokines (IFN-g and TNF-a) and Th2 cytokines (IL-4 and IL-10) in the serum, indicating that administration of aGC via an intraperitoneal route induces both local and systemic inflammatory responses. The simultaneous increase in Th1 and Th2 cytokines suggests a non-biased cytokine secretion upon aGC exposure, which is in agreement with the results of Boyson et al.
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In our study, treatment with aGC decreased the number of viable fetuses and increased the ERR in WT mice but not in Ja18 À / À mice, suggesting that Va14 NKT cells are indispensable in aGC-induced pregnancy loss. Adoptive transfer of iNKT cells from WT mice into aGC-treated Ja18 À / À mice restored aGC-mediated pregnancy loss, confirming the critical role played by iNKT cells in inflammation-mediated pregnancy loss. In addition, adoptive transfer of iNKT cells from IL-4 À / À mice but not from IFN-g À / À mice promoted fetal loss in aGCtreated Ja18 À / À mice, demonstrating that iNKT cell-mediated pregnancy loss is IFN-g-dependent, but not IL-4-dependent.
Similarly, administration of aGC increased the levels of serum cytokines in WT mice but not in Ja18 À / À mice.
Adoptive transfer of iNKT cells from WT mice or IL-4
À / À mice but not from IFN-g À / À mice augmented serum cytokine production in aGC-treated Ja18 À / À mice, suggesting that IFN-g is also necessary in iNKT cell-induced upregulation of serum cytokine production. Th1 cytokines, including IFN-g and TNF-a, have been implicated in pregnancy loss. 28, 29 Th2 cytokines, such as IL-4 and IL-10, are pleiotropic cytokines that suppress pro-inflammatory responses. 30 During pregnancy, Th2 cytokines increase markedly and promote fetal allograft tolerance by inhibiting Th1 responses. 31 In the present study, although aGC induced elevated production of Th1 and Th2 cytokines both at the maternal-fetal interface and in the serum, iNKT cell-mediated pregnancy loss required IFN-g but not IL-4. We hypothesize that the elevated Th2 cytokines may not be able to counteract the pro-inflammatory responses induced by increased Th1 cytokines. Indeed, IL-4 and IL-10 have been shown to be non-essential for fetal survival as the litter size and development in IL-4 and IL-10 double-deficient mice are not different from those in WT mice. 32 To our knowledge, reports on the interplay between iNKT cells and Treg cells at the maternal-fetal interface are scarce or absent. In the present study, we investigated the role of Treg cells in iNKT cell-mediated pregnancy loss. There are several lines of evidence supporting an essential role for Treg cells in the generation of maternal-fetal tolerance. First, Treg cells 
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MucosalImmunology | VOLUME 10 NUMBER 3 | MAY 2017 increase significantly in the peripheral blood, decidual tissue, and lymph nodes draining the uterus during human and murine pregnancy. 33, 34 It has been suggested that Treg cells at the maternal-fetal interface are mainly of extra-thymic origin. 35 However, recruitment of naturally occurring Treg cells cannot be ruled out as genetic depletion of induced Treg cells in mice lacking conserved non-coding sequence 1 enhancer element in the first intron of the Fxop3 gene, which is necessary for induced Treg cell generation, only results in mildly increased pregnancy loss. 36 Second, spontaneous abortion cases are associated with a reduction in the number and suppressive capacity of Treg cells. 37 Third, Ab-mediated depletion of CD25 þ Treg cells induces implantation failure and fetal wastage in mice. 19, 38 Finally, adoptive transfer of pregnancy-induced Treg cells prevents fetal rejection in a murine abortion model. 39 
Activation of human naive CD4
þ T cells induces Foxp3 expression, obscuring the identification of Foxp3 þ T cells as pure Treg cells. 40 In contrast, mouse naive CD4 þ T cells lack Foxp3 expression following activation. 15 In our study, mouse Treg cells were therefore identified as CD4 þ Foxp3 þ cells. Pathways activated by Treg cell-secreted IL-10 and TGF-b are important in Treg cell suppressive activities. 15 IL-10 decreases dendritic cell maturation 41 and converts Tcon cells into IL-10-secreting T regulatory type 1 cells. 42 
TGF-b induces Foxp3 expression in Tcon cells and promotes the conversion of peripheral CD4
þ CD25 -naive T cells into CD4 þ CD25 þ Treg cells. 43 We found that the activation of iNKT cells decreased the frequency of decidual Treg cells, Treg cell production of IL-10 and TGF-b, and Treg cell suppressive activity, indicating that iNKT cell-mediated suppression of decidual Treg cell function may have a role in aGC-induced inflammatory pregnancy loss.
As it is difficult to isolate Treg cells using intracellular Foxp3, and CD4
þ Foxp3 þ Treg cells in naive mice can be identified by the expression of CD25, 44 we isolated mouse Treg cells using the cell surface markers CD4 and CD25. We found that adoptive transfer of Treg cells decreased fetal resorption in aGC-treated WT mice, further confirming a feedback pathway for Treg cells during the generation of maternal-fetal tolerance and aGC-induced pregnancy loss through suppression of Treg cells. Nevertheless, adoptive transfer of Treg cells did not restore the ERR to the extent seen in vehicle-treated control mice, demonstrating that other mechanisms may also be involved in iNKT cell-mediated fetal loss. Activated iNKT cells can activate other immune cells such as T cells, dendritic cells, and NK cells. 11 These activated cells have been demonstrated to have a role in disrupting maternal-fetal tolerance. 45, 46 In spite of their restricted TCR repertoire, iNKT cells can respond to a considerable variety of microbial pathogens ranging from viruses to parasites. In addition to directly recognizing various naturally occurring microbial lipids through the TCR, iNKT cells are also able to respond to a diverse array of microbes through inflammatory cytokines produced by antigen presenting cells upon Toll-like receptor stimulation. 47 For instance, the Toll-like receptor 4 ligand Escherichia coli lipopolysaccharide, which is associated with inflammatory pregnancy loss, 48 is able to indirectly activate iNKT cells through inflammatory cytokines IL-12 and IL-18. 49 Both direct and indirect activation of iNKT cells enables them respond to a wide variety of microbes and contribute to inflammation-mediated pregnancy loss.
In summary, IP injection of aGC rapidly induces pregnancy loss, and IFN-g is indispensable in iNKT cell-mediated pregnancy loss. In addition, this process is at least partly accomplished by restraining the suppressive function of Treg cells.
METHODS
Animals. Eight-week-old C57BL/6 mice were purchased from the Experimental Animal Center of Zhongshan University (Guangzhou, China). INF-g À / À and IL-4 À / À mice on a C57BL/6 background were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). iNKT cell-deficient Ja18 À / À mice on a C57BL/6 background were kindly provided by Taniguchi (RIKEN Institute, Yokohama, Japan). 50 Mice were bred in the Laboratory Animal Center of Guangzhou Medical University (Guangzhou, China) in pathogen-free conditions. Ja18 À / À mice were backcrossed at least 10 generations with C57BL/6 mice. Syngeneic C57BL/6 Â C57BL/6 and Ja18 À / À Â Ja18 À / À mating combinations were established. Each female mouse was cocaged with one male. The point at which a vaginal plug was detected was designated as day 0.5 of gestation. All experimental research on animals was approved by the Animal Care and Use Committee of Guangzhou Medical University.
aGC-induced abortion model. As described previously, 27 on day 9.5 of gestation, pregnant C57BL/6 and Ja18 À / À mice were injected IP with aGC (100 mg kg À 1 body weight) (Sigma, Saint Louis, MO, USA) in phosphate-buffered solution and 0.5% polysorbate-20 or vehicle alone taking care not to enter the amniotic cavity. In selected experiments, C57BL/6 mice were injected IP with 10 mg recombinant mouse IFN-g (Biolegend, San Diego, CA, USA). Animals were observed closely for any signs of morbidity (piloerection, decreased movement, and vaginal bleeding). Pregnant mice were killed after 72 h (day 12.5 of gestation). At this stage of gestation, feto-placental units undergoing resorption can be clearly distinguished from their viable counterparts on the basis of small size and the presence of extensive tissue wasting and hemorrhage. The number of total fetuses, viable fetuses, and resorbed embryos per mouse were counted. ERR was calculated as: ERR (%) ¼ number of resorbed embryos/number of total embryos Â 100. 27 Some mice were killed 12 h after aGC injection. Serum was obtained from the tail vein and decidual mononuclear cells (MNCs) and Treg cells were isolated. The levels of IFN-g, TNF-a, IL-4, and IL-10 in the serum were assayed using enzyme-linked immunosorbent assay (ELISA). The percentages of iNKT cells and Treg cells, iNKT cell intracellular IFN-g and IL-4 production, and Treg cell intracellular IL-10 and TGF-b production were measured using flow cytometry. The suppressive activity of decidual Treg cells was analyzed (see below).
Adoptive transfer of decidual iNKT cells or Treg cells. As murine iNKT cells increase during the early and middle gestation, 51 for iNKT cell reconstitution of Ja18 À / À mice, 5 Â 10 5 purified iNKT cells from the spleens of pregnant WT, IFN-g À / À , or IL-4 À / À mice on day 12.5 of gestation were injected into the tail veins of Ja18 À / À mice 2 h before aGC injection on day 9.5 of gestation. It has been reported that murine Treg cells increase during early pregnancy and peak during the midgestation. 52 For Treg cell reconstitution of WT mice, 5 Â 10 5 purified Treg cells from the spleens of pregnant WT mice on day 12.5 of gestation were injected into the tail veins of C57BL/6 mice 2 h before aGC injection on day 9.5 of gestation. Mice were killed 72 h after aGC injection and the number of total fetuses and viable embryos per mouse, and ERRs were calculated. Some mice were killed 12 h after aGC injection. Serum was collected and analyzed for cytokine production.
Isolation of splenocytes. Spleens were mashed through a 40 mm cell strainer (Thermo Fisher Scientific, Waltham, MA, USA) to obtain single-cell suspensions. Splenocytes were then enriched by lysing red cells using a red cell lysis buffer (Biolegend).
Isolation of decidual MNCs. The uterine horns of pregnant mice were opened longitudinally, and the entire placental and decidual units were separated individually from the corresponding embryo and its implantation site. After washing in phosphate-buffered solution, pooled decidual tissues were cut into small pieces and digested three times with 1 mg ml À 1 Dispase II (Roche, Basel, Switzerland) at 37 1C for 20 min each cycle in a shaking water bath. When single or clumps of cells were observed under the microscope, the released cells were separated from undigested tissue pieces by filtering through a 40 mmpore nylon mesh strainer (Thermo Fisher Scientific). MNCs were purified over a Ficoll-Paque Premium (GE Healthcare, Pittsburgh, PA, USA) by centrifugation at 400 g for 30 min at 20 1C.
Generation of iNKT cells. Isolation of iNKT cells has been described previously. 53 Briefly, splenocytes or decidual MNCs were prepared and labeled with B220 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). B cells were depleted from decidual MNCs using an autoMACS separator (Miltenyi Biotec). The B-cell-free fractions were then labeled with phycoerythrin (PE)-conjugated aGC-loaded CD1d tetramer (Miltenyi Biotec), washed and enriched for CD1d-aGC tetramer þ iNKT cells using anti-PE-microbeads (Miltenyi Biotec) and the autoMACS separator. The purity of sorted iNKT cells was defined as the percentage of CD1d-aGC tetramer þ CD3 þ cells in the CD3 þ cell population and routinely exceeded 97%, as determined using flow cytometry (data not shown).
Isolation of T-cell subsets. For adoptive transfer, Treg cells were isolated from the spleens of C57BL/6 mice on day 12.5 of gestation using a mouse CD4 þ CD25 þ Treg cell isolation kit (Miltenyi Biotec) according to the manufacturer's instructions. For in vitro co-culture experiments, CD4 þ CD25 þ Treg cells and CD4 þ CD25 À Tcon cells were sorted from the decidua of pregnant C57BL/6 mice. In brief, splenocytes or decidual MNC suspensions from C57BL/6 mice were prepared. The single-cell suspensions were then labeled with a biotinAb cocktail, washed and incubated with anti-biotin microbeads and CD25-PE Ab. Non-CD4 þ T cells were then magnetically depleted using the autoMACS separator. Unlabeled CD4 þ T cells were collected and incubated with anti-PE microbeads. CD4 þ CD25 þ Treg cells and CD4 þ CD25 À Tcon cells were separately isolated using the autoMACS separator. The suppressive activity of decidual Treg cells was also investigated by assessing cytokine production by CD4 þ CD25 À Tcon cells cocultured with decidual Treg cells. 54 Briefly, sorted decidual Tcon cells (5 Â 10 4 cells) were co-cultured with decidual Treg cells (5 Â 10 4 cells) from aGC-treated or vehicle-treated C57BL/6 mice with 50 ng ml À 1 phorbol myristate acetate (Sigma) and 500 ng ml À 1 ionomycin (Sigma) for 48 h. Cell culture supernatants were analyzed for IFNg and TNF-a secretion using ELISA.
Flow cytometry. For iNKT cell analysis, cells were incubated with allophycocyanin (APC)/Cy7-conjugated anti-CD3 Ab (0.25 mg) and PE-conjugated anti-aGC-loaded CD1d tetramer Ab (1 mg) for 30 min at 4 1C. After washing twice with phosphate-buffered solution, cells were fixed in a fixation buffer. For intracellular cytokine staining, cells were resuspended in a permeabilization wash buffer and incubated with fluorescein isothiocyanate-conjugated anti-IFN-g Ab (1 mg) and APC-conjugated anti-IL-4 Ab (1 mg). For Treg cell analysis, cells were incubated with fluorescein isothiocyanate-conjugated anti-CD4 Ab (0.25 mg) for 30 min at 4 1C. After washing twice with phosphate-buffered solution, cells were fixed in a fixation buffer. Cells were then resuspended in a permeabilization wash buffer and incubated with PE-conjugated anti-Foxp3 Ab (1.0 mg), PE/Cy7-conjugated anti-IL-10 (0.25 mg), and APC-conjugated anti-TGF-b (0.5 mg) Abs. Isotype controls were established using matched fluorescence-labeled isotype control antibodies to account for nonspecific staining. Immunostained cells were analyzed on a FACSCanto flow cytometer using FlowJo software. The percentage of CD1d-aGC tetramer þ cells in the CD3 þ cell population was measured. CD1d-aGC tetramer þ CD3 þ cells were gated and screened for intracellular IFN-g and IL-4 production. The percentage of Foxp3 þ cells in the CD4 þ cell population was assayed. Foxp3 þ CD4 þ cells were gated and screened for intracellular IL-10 and TGF-b production. Fluorescence-conjugated Abs, matched fluorescence-labeled isotype control Abs, permeabilization wash buffer, and fixation buffer were all purchased from BioLegend.
ELISA. Serums and cell culture supernatants were collected and stored at À 80 1C for batched cytokine examination. The levels of IFN-g, TNF-a, IL-4, and IL-10 were assessed using commercially available ELISA kits (R&D Systems, Minneapolis, MN, USA). All assays were conducted according to the manufacturer's instructions.
Statistical analysis. All statistical analyses were performed using SPSS 23.0 software (IBM, Armonk, NY, USA). For multiple group comparisons, data were analyzed using one-way analysis of variance with Bonferroni post-test when the variances were homogeneous or with Tamhane's T2 post-test when the variances were not homogeneous. Independent Student's t-test was used for comparisons between two groups. Results were expressed as mean ± s.d. A P-value of o0.05 was considered significant.
